Justin Bowers
Stock Analyst at Deutsche Bank
(0.73)
# 3,787
Out of 4,349 analysts
142
Total ratings
41.3%
Success rate
-2.6%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Maintained: Buy | $72 → $66 | $50.84 | +29.82% | 8 | May 8, 2026 | |
| TXG 10x Genomics | Maintained: Hold | $17 → $23 | $27.99 | -17.83% | 9 | May 8, 2026 | |
| MRVI Maravai LifeSciences Holdings | Maintained: Buy | $10 → $6 | $4.64 | +29.31% | 6 | May 8, 2026 | |
| CON Concentra Group Holdings Parent | Maintained: Buy | $29 → $32 | $25.36 | +26.18% | 2 | May 8, 2026 | |
| WAT Waters | Maintained: Hold | $330 → $350 | $366.67 | -4.55% | 10 | May 7, 2026 | |
| FTRE Fortrea Holdings | Maintained: Hold | $14 | $15.00 | -6.67% | 6 | May 7, 2026 | |
| SEM Select Medical Holdings | Downgraded: Hold | $50 → $17 | $16.51 | -0.06% | 23 | Mar 4, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | $345 → $315 | $321.80 | -2.11% | 6 | Feb 13, 2026 | |
| DHR Danaher | Maintained: Buy | $270 | $180.63 | +49.48% | 10 | Jan 29, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $630 → $620 | $487.22 | +27.25% | 9 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 → $185 | $181.34 | +2.02% | 11 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $220 | $181.09 | +21.49% | 16 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $336 → $430 | $448.12 | -4.04% | 3 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $155 → $175 | $122.73 | n/a | 8 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $9.15 | n/a | 6 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $300 → $370 | $136.80 | n/a | 7 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $70 | $105.36 | n/a | 1 | Sep 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $140 | $158.70 | n/a | 1 | Jan 17, 2014 |
Bio-Techne
May 8, 2026
Maintained: Buy
Price Target: $72 → $66
Current: $50.84
Upside: +29.82%
10x Genomics
May 8, 2026
Maintained: Hold
Price Target: $17 → $23
Current: $27.99
Upside: -17.83%
Maravai LifeSciences Holdings
May 8, 2026
Maintained: Buy
Price Target: $10 → $6
Current: $4.64
Upside: +29.31%
Concentra Group Holdings Parent
May 8, 2026
Maintained: Buy
Price Target: $29 → $32
Current: $25.36
Upside: +26.18%
Waters
May 7, 2026
Maintained: Hold
Price Target: $330 → $350
Current: $366.67
Upside: -4.55%
Fortrea Holdings
May 7, 2026
Maintained: Hold
Price Target: $14
Current: $15.00
Upside: -6.67%
Select Medical Holdings
Mar 4, 2026
Downgraded: Hold
Price Target: $50 → $17
Current: $16.51
Upside: -0.06%
West Pharmaceutical Services
Feb 13, 2026
Maintained: Buy
Price Target: $345 → $315
Current: $321.80
Upside: -2.11%
Danaher
Jan 29, 2026
Maintained: Buy
Price Target: $270
Current: $180.63
Upside: +49.48%
Thermo Fisher Scientific
Oct 23, 2025
Maintained: Buy
Price Target: $630 → $620
Current: $487.22
Upside: +27.25%
Aug 7, 2025
Maintained: Buy
Price Target: $180 → $185
Current: $181.34
Upside: +2.02%
Jul 29, 2025
Maintained: Buy
Price Target: $260 → $220
Current: $181.09
Upside: +21.49%
Jul 23, 2025
Maintained: Hold
Price Target: $336 → $430
Current: $448.12
Upside: -4.04%
Aug 16, 2024
Maintained: Buy
Price Target: $155 → $175
Current: $122.73
Upside: n/a
Jul 26, 2024
Maintained: Hold
Price Target: $25
Current: $9.15
Upside: n/a
Jul 24, 2024
Maintained: Buy
Price Target: $300 → $370
Current: $136.80
Upside: n/a
Sep 16, 2019
Initiated Coverage: Hold
Price Target: $70
Current: $105.36
Upside: n/a
Jan 17, 2014
Maintained: Buy
Price Target: $140
Current: $158.70
Upside: n/a